chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Varicella virus test negative, Vertebral artery aneurysm, Vertebral artery stenosis, Viral test negative, Vomiting
Clinical narrative: Multi system organ failure; Renal failure; Shock; Cardiac tamponade; Multifocal small stroke; Systemic inflammation and hyperinflammation; Hearing loss; Pleural effusion; Neo pressure; This is a spontaneous report from a contactable Physician via medical information center. A male patient of an unspecified age (Age: 20; Unit: unknown) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot/Batch number: Not reported) via unspecified route of administration on an unknown date as 1st dose single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unknown date in May2021, the patient experienced multi system organ failure, renal failure, shock, neo pressure (hypotension), cardiac tamponade, pleural effusion, multifocal small stroke (transient ischaemic attack), systemic inflammation (systemic inflammatory response syndrome), hearing loss (deafness). The outcome of the events was unknown.  Physician commented: HCP wanted to know reports of similar cases such as a male patient (20 years old) experienced after the first dose of the Pfizer covid vaccine. He experienced multi system organ failure, renal failure, shock, neo pressure, cardiac tamponade requiring pericardial window, pleural effusion requiring chest tube, hearing loss, multifocal small stroke, systemic inflammation and hyperinflammation. HCP is looking for guidance on treatment as well. Informed the physician that we can do some more research on their question to see if there was any additional information available.  Information related to batch/Lot no. was requested.; Sender's Comments: There is limited information provided in this report. Additional information is needed to better assess the case, including complete medical history, concomitant medications,age of the patient, date of vaccine given, date on when the event started ,lab reports etc. The case will be reevaluated should additional information become available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: White blood cells urine positive
Clinical narrative: Multi system organ failure; Renal failure; Shock; Cardiac tamponade; Multifocal small stroke; Systemic inflammation and hyperinflammation; Hearing loss; Pleural effusion; Neo pressure; This is a spontaneous report from a contactable Physician via medical information center. A male patient of an unspecified age (Age: 20; Unit: unknown) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot/Batch number: Not reported) via unspecified route of administration on an unknown date as 1st dose single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unknown date in May2021, the patient experienced multi system organ failure, renal failure, shock, neo pressure (hypotension), cardiac tamponade, pleural effusion, multifocal small stroke (transient ischaemic attack), systemic inflammation (systemic inflammatory response syndrome), hearing loss (deafness). The outcome of the events was unknown.  Physician commented: HCP wanted to know reports of similar cases such as a male patient (20 years old) experienced after the first dose of the Pfizer covid vaccine. He experienced multi system organ failure, renal failure, shock, neo pressure, cardiac tamponade requiring pericardial window, pleural effusion requiring chest tube, hearing loss, multifocal small stroke, systemic inflammation and hyperinflammation. HCP is looking for guidance on treatment as well. Informed the physician that we can do some more research on their question to see if there was any additional information available.  Information related to batch/Lot no. was requested.; Sender's Comments: There is limited information provided in this report. Additional information is needed to better assess the case, including complete medical history, concomitant medications,age of the patient, date of vaccine given, date on when the event started ,lab reports etc. The case will be reevaluated should additional information become available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cardiac tamponade, Deafness, Hypotension, Multiple organ dysfunction syndrome, Pleural effusion
Clinical narrative: Multi system organ failure; Renal failure; Shock; Cardiac tamponade; Multifocal small stroke; Systemic inflammation and hyperinflammation; Hearing loss; Pleural effusion; Neo pressure; This is a spontaneous report from a contactable Physician via medical information center. A male patient of an unspecified age (Age: 20; Unit: unknown) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot/Batch number: Not reported) via unspecified route of administration on an unknown date as 1st dose single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unknown date in May2021, the patient experienced multi system organ failure, renal failure, shock, neo pressure (hypotension), cardiac tamponade, pleural effusion, multifocal small stroke (transient ischaemic attack), systemic inflammation (systemic inflammatory response syndrome), hearing loss (deafness). The outcome of the events was unknown.  Physician commented: HCP wanted to know reports of similar cases such as a male patient (20 years old) experienced after the first dose of the Pfizer covid vaccine. He experienced multi system organ failure, renal failure, shock, neo pressure, cardiac tamponade requiring pericardial window, pleural effusion requiring chest tube, hearing loss, multifocal small stroke, systemic inflammation and hyperinflammation. HCP is looking for guidance on treatment as well. Informed the physician that we can do some more research on their question to see if there was any additional information available.  Information related to batch/Lot no. was requested.; Sender's Comments: There is limited information provided in this report. Additional information is needed to better assess the case, including complete medical history, concomitant medications,age of the patient, date of vaccine given, date on when the event started ,lab reports etc. The case will be reevaluated should additional information become available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Renal failure, Shock, Systemic inflammatory response syndrome, Transient ischaemic attack
Clinical narrative: Multi system organ failure; Renal failure; Shock; Cardiac tamponade; Multifocal small stroke; Systemic inflammation and hyperinflammation; Hearing loss; Pleural effusion; Neo pressure; This is a spontaneous report from a contactable Physician via medical information center. A male patient of an unspecified age (Age: 20; Unit: unknown) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot/Batch number: Not reported) via unspecified route of administration on an unknown date as 1st dose single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unknown date in May2021, the patient experienced multi system organ failure, renal failure, shock, neo pressure (hypotension), cardiac tamponade, pleural effusion, multifocal small stroke (transient ischaemic attack), systemic inflammation (systemic inflammatory response syndrome), hearing loss (deafness). The outcome of the events was unknown.  Physician commented: HCP wanted to know reports of similar cases such as a male patient (20 years old) experienced after the first dose of the Pfizer covid vaccine. He experienced multi system organ failure, renal failure, shock, neo pressure, cardiac tamponade requiring pericardial window, pleural effusion requiring chest tube, hearing loss, multifocal small stroke, systemic inflammation and hyperinflammation. HCP is looking for guidance on treatment as well. Informed the physician that we can do some more research on their question to see if there was any additional information available.  Information related to batch/Lot no. was requested.; Sender's Comments: There is limited information provided in this report. Additional information is needed to better assess the case, including complete medical history, concomitant medications,age of the patient, date of vaccine given, date on when the event started ,lab reports etc. The case will be reevaluated should additional information become available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute kidney injury, Biopsy kidney, Blood creatinine, Blood lactate dehydrogenase, C-reactive protein
Clinical narrative: Multi system organ failure; Renal failure; Shock; Cardiac tamponade; Multifocal small stroke; Systemic inflammation and hyperinflammation; Hearing loss; Pleural effusion; Neo pressure; This is a spontaneous report from a contactable Physician via medical information center. A male patient of an unspecified age (Age: 20; Unit: unknown) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot/Batch number: Not reported) via unspecified route of administration on an unknown date as 1st dose single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unknown date in May2021, the patient experienced multi system organ failure, renal failure, shock, neo pressure (hypotension), cardiac tamponade, pleural effusion, multifocal small stroke (transient ischaemic attack), systemic inflammation (systemic inflammatory response syndrome), hearing loss (deafness). The outcome of the events was unknown.  Physician commented: HCP wanted to know reports of similar cases such as a male patient (20 years old) experienced after the first dose of the Pfizer covid vaccine. He experienced multi system organ failure, renal failure, shock, neo pressure, cardiac tamponade requiring pericardial window, pleural effusion requiring chest tube, hearing loss, multifocal small stroke, systemic inflammation and hyperinflammation. HCP is looking for guidance on treatment as well. Informed the physician that we can do some more research on their question to see if there was any additional information available.  Information related to batch/Lot no. was requested.; Sender's Comments: There is limited information provided in this report. Additional information is needed to better assess the case, including complete medical history, concomitant medications,age of the patient, date of vaccine given, date on when the event started ,lab reports etc. The case will be reevaluated should additional information become available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Capillary leak syndrome, Chemokine test, Computerised tomogram, Cytokine test, Deafness neurosensory
Clinical narrative: Multi system organ failure; Renal failure; Shock; Cardiac tamponade; Multifocal small stroke; Systemic inflammation and hyperinflammation; Hearing loss; Pleural effusion; Neo pressure; This is a spontaneous report from a contactable Physician via medical information center. A male patient of an unspecified age (Age: 20; Unit: unknown) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot/Batch number: Not reported) via unspecified route of administration on an unknown date as 1st dose single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unknown date in May2021, the patient experienced multi system organ failure, renal failure, shock, neo pressure (hypotension), cardiac tamponade, pleural effusion, multifocal small stroke (transient ischaemic attack), systemic inflammation (systemic inflammatory response syndrome), hearing loss (deafness). The outcome of the events was unknown.  Physician commented: HCP wanted to know reports of similar cases such as a male patient (20 years old) experienced after the first dose of the Pfizer covid vaccine. He experienced multi system organ failure, renal failure, shock, neo pressure, cardiac tamponade requiring pericardial window, pleural effusion requiring chest tube, hearing loss, multifocal small stroke, systemic inflammation and hyperinflammation. HCP is looking for guidance on treatment as well. Informed the physician that we can do some more research on their question to see if there was any additional information available.  Information related to batch/Lot no. was requested.; Sender's Comments: There is limited information provided in this report. Additional information is needed to better assess the case, including complete medical history, concomitant medications,age of the patient, date of vaccine given, date on when the event started ,lab reports etc. The case will be reevaluated should additional information become available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Echocardiogram, Fibrin D dimer, Inflammatory marker test, Interleukin level, Interleukin level increased
Clinical narrative: Multi system organ failure; Renal failure; Shock; Cardiac tamponade; Multifocal small stroke; Systemic inflammation and hyperinflammation; Hearing loss; Pleural effusion; Neo pressure; This is a spontaneous report from a contactable Physician via medical information center. A male patient of an unspecified age (Age: 20; Unit: unknown) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot/Batch number: Not reported) via unspecified route of administration on an unknown date as 1st dose single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unknown date in May2021, the patient experienced multi system organ failure, renal failure, shock, neo pressure (hypotension), cardiac tamponade, pleural effusion, multifocal small stroke (transient ischaemic attack), systemic inflammation (systemic inflammatory response syndrome), hearing loss (deafness). The outcome of the events was unknown.  Physician commented: HCP wanted to know reports of similar cases such as a male patient (20 years old) experienced after the first dose of the Pfizer covid vaccine. He experienced multi system organ failure, renal failure, shock, neo pressure, cardiac tamponade requiring pericardial window, pleural effusion requiring chest tube, hearing loss, multifocal small stroke, systemic inflammation and hyperinflammation. HCP is looking for guidance on treatment as well. Informed the physician that we can do some more research on their question to see if there was any additional information available.  Information related to batch/Lot no. was requested.; Sender's Comments: There is limited information provided in this report. Additional information is needed to better assess the case, including complete medical history, concomitant medications,age of the patient, date of vaccine given, date on when the event started ,lab reports etc. The case will be reevaluated should additional information become available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Interleukin-2 receptor assay, Investigation, Ischaemic stroke, Laboratory test, Lymphocyte count
Clinical narrative: Multi system organ failure; Renal failure; Shock; Cardiac tamponade; Multifocal small stroke; Systemic inflammation and hyperinflammation; Hearing loss; Pleural effusion; Neo pressure; This is a spontaneous report from a contactable Physician via medical information center. A male patient of an unspecified age (Age: 20; Unit: unknown) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot/Batch number: Not reported) via unspecified route of administration on an unknown date as 1st dose single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unknown date in May2021, the patient experienced multi system organ failure, renal failure, shock, neo pressure (hypotension), cardiac tamponade, pleural effusion, multifocal small stroke (transient ischaemic attack), systemic inflammation (systemic inflammatory response syndrome), hearing loss (deafness). The outcome of the events was unknown.  Physician commented: HCP wanted to know reports of similar cases such as a male patient (20 years old) experienced after the first dose of the Pfizer covid vaccine. He experienced multi system organ failure, renal failure, shock, neo pressure, cardiac tamponade requiring pericardial window, pleural effusion requiring chest tube, hearing loss, multifocal small stroke, systemic inflammation and hyperinflammation. HCP is looking for guidance on treatment as well. Informed the physician that we can do some more research on their question to see if there was any additional information available.  Information related to batch/Lot no. was requested.; Sender's Comments: There is limited information provided in this report. Additional information is needed to better assess the case, including complete medical history, concomitant medications,age of the patient, date of vaccine given, date on when the event started ,lab reports etc. The case will be reevaluated should additional information become available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Magnetic resonance imaging head, Multiple organ dysfunction syndrome, Multisystem inflammatory syndrome, Pericardial effusion, Physical examination
Clinical narrative: Multi system organ failure; Renal failure; Shock; Cardiac tamponade; Multifocal small stroke; Systemic inflammation and hyperinflammation; Hearing loss; Pleural effusion; Neo pressure; This is a spontaneous report from a contactable Physician via medical information center. A male patient of an unspecified age (Age: 20; Unit: unknown) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot/Batch number: Not reported) via unspecified route of administration on an unknown date as 1st dose single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unknown date in May2021, the patient experienced multi system organ failure, renal failure, shock, neo pressure (hypotension), cardiac tamponade, pleural effusion, multifocal small stroke (transient ischaemic attack), systemic inflammation (systemic inflammatory response syndrome), hearing loss (deafness). The outcome of the events was unknown.  Physician commented: HCP wanted to know reports of similar cases such as a male patient (20 years old) experienced after the first dose of the Pfizer covid vaccine. He experienced multi system organ failure, renal failure, shock, neo pressure, cardiac tamponade requiring pericardial window, pleural effusion requiring chest tube, hearing loss, multifocal small stroke, systemic inflammation and hyperinflammation. HCP is looking for guidance on treatment as well. Informed the physician that we can do some more research on their question to see if there was any additional information available.  Information related to batch/Lot no. was requested.; Sender's Comments: There is limited information provided in this report. Additional information is needed to better assess the case, including complete medical history, concomitant medications,age of the patient, date of vaccine given, date on when the event started ,lab reports etc. The case will be reevaluated should additional information become available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pleural effusion, Red blood cell sedimentation rate, Troponin T, Urine analysis, Vital signs measurement
Clinical narrative: Multi system organ failure; Renal failure; Shock; Cardiac tamponade; Multifocal small stroke; Systemic inflammation and hyperinflammation; Hearing loss; Pleural effusion; Neo pressure; This is a spontaneous report from a contactable Physician via medical information center. A male patient of an unspecified age (Age: 20; Unit: unknown) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot/Batch number: Not reported) via unspecified route of administration on an unknown date as 1st dose single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unknown date in May2021, the patient experienced multi system organ failure, renal failure, shock, neo pressure (hypotension), cardiac tamponade, pleural effusion, multifocal small stroke (transient ischaemic attack), systemic inflammation (systemic inflammatory response syndrome), hearing loss (deafness). The outcome of the events was unknown.  Physician commented: HCP wanted to know reports of similar cases such as a male patient (20 years old) experienced after the first dose of the Pfizer covid vaccine. He experienced multi system organ failure, renal failure, shock, neo pressure, cardiac tamponade requiring pericardial window, pleural effusion requiring chest tube, hearing loss, multifocal small stroke, systemic inflammation and hyperinflammation. HCP is looking for guidance on treatment as well. Informed the physician that we can do some more research on their question to see if there was any additional information available.  Information related to batch/Lot no. was requested.; Sender's Comments: There is limited information provided in this report. Additional information is needed to better assess the case, including complete medical history, concomitant medications,age of the patient, date of vaccine given, date on when the event started ,lab reports etc. The case will be reevaluated should additional information become available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Angiogram, Arthralgia, Blood test, C-reactive protein increased, Catheterisation cardiac
Clinical narrative: The patient had his 2nd Moderna vaccine on 4/21/21.  He had headache and malaise for 2 days that resolved. On 4/24, he developed chest pain radiating to his jaw and left upper arm.  He presented to the ED, he had an elevated troponin of 2.24 increased to 12.87. EKG showed ST elevation consistent with myocarditis.  He was transferred to RRH and underwent cardiac cath on 4/26 which showed no CAD. He was not febrile.  He was treated with metoprolol
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest X-ray, Chest discomfort, Cold sweat, Dizziness, Drug screen
Clinical narrative: The patient had his 2nd Moderna vaccine on 4/21/21.  He had headache and malaise for 2 days that resolved. On 4/24, he developed chest pain radiating to his jaw and left upper arm.  He presented to the ED, he had an elevated troponin of 2.24 increased to 12.87. EKG showed ST elevation consistent with myocarditis.  He was transferred to RRH and underwent cardiac cath on 4/26 which showed no CAD. He was not febrile.  He was treated with metoprolol
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Echocardiogram, Electrocardiogram, Full blood count, Glycosylated haemoglobin decreased, Laboratory test
Clinical narrative: The patient had his 2nd Moderna vaccine on 4/21/21.  He had headache and malaise for 2 days that resolved. On 4/24, he developed chest pain radiating to his jaw and left upper arm.  He presented to the ED, he had an elevated troponin of 2.24 increased to 12.87. EKG showed ST elevation consistent with myocarditis.  He was transferred to RRH and underwent cardiac cath on 4/26 which showed no CAD. He was not febrile.  He was treated with metoprolol
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Lipids, Low density lipoprotein normal, Metabolic function test, Musculoskeletal discomfort, Pain in extremity
Clinical narrative: The patient had his 2nd Moderna vaccine on 4/21/21.  He had headache and malaise for 2 days that resolved. On 4/24, he developed chest pain radiating to his jaw and left upper arm.  He presented to the ED, he had an elevated troponin of 2.24 increased to 12.87. EKG showed ST elevation consistent with myocarditis.  He was transferred to RRH and underwent cardiac cath on 4/26 which showed no CAD. He was not febrile.  He was treated with metoprolol
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Paraesthesia, Prothrombin time normal, Red blood cell sedimentation rate increased, SARS-CoV-2 test negative, Troponin increased
Clinical narrative: The patient had his 2nd Moderna vaccine on 4/21/21.  He had headache and malaise for 2 days that resolved. On 4/24, he developed chest pain radiating to his jaw and left upper arm.  He presented to the ED, he had an elevated troponin of 2.24 increased to 12.87. EKG showed ST elevation consistent with myocarditis.  He was transferred to RRH and underwent cardiac cath on 4/26 which showed no CAD. He was not febrile.  He was treated with metoprolol
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: C-reactive protein increased, Catheterisation cardiac normal, Chest pain, Drug screen negative, Echocardiogram normal
Clinical narrative: The patient had his 2nd Moderna vaccine on 4/21/21.  He had headache and malaise for 2 days that resolved. On 4/24, he developed chest pain radiating to his jaw and left upper arm.  He presented to the ED, he had an elevated troponin of 2.24 increased to 12.87. EKG showed ST elevation consistent with myocarditis.  He was transferred to RRH and underwent cardiac cath on 4/26 which showed no CAD. He was not febrile.  He was treated with metoprolol
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Electrocardiogram ST segment elevation, Electrocardiogram abnormal, Full blood count normal, Glycosylated haemoglobin, Headache
Clinical narrative: The patient had his 2nd Moderna vaccine on 4/21/21.  He had headache and malaise for 2 days that resolved. On 4/24, he developed chest pain radiating to his jaw and left upper arm.  He presented to the ED, he had an elevated troponin of 2.24 increased to 12.87. EKG showed ST elevation consistent with myocarditis.  He was transferred to RRH and underwent cardiac cath on 4/26 which showed no CAD. He was not febrile.  He was treated with metoprolol
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Lipids normal, Malaise, Metabolic function test, Myocarditis, Pain
Clinical narrative: The patient had his 2nd Moderna vaccine on 4/21/21.  He had headache and malaise for 2 days that resolved. On 4/24, he developed chest pain radiating to his jaw and left upper arm.  He presented to the ED, he had an elevated troponin of 2.24 increased to 12.87. EKG showed ST elevation consistent with myocarditis.  He was transferred to RRH and underwent cardiac cath on 4/26 which showed no CAD. He was not febrile.  He was treated with metoprolol
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pain in extremity, Pain in jaw, Red blood cell sedimentation rate increased, Troponin increased
Clinical narrative: The patient had his 2nd Moderna vaccine on 4/21/21.  He had headache and malaise for 2 days that resolved. On 4/24, he developed chest pain radiating to his jaw and left upper arm.  He presented to the ED, he had an elevated troponin of 2.24 increased to 12.87. EKG showed ST elevation consistent with myocarditis.  He was transferred to RRH and underwent cardiac cath on 4/26 which showed no CAD. He was not febrile.  He was treated with metoprolol
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute myocardial infarction, Anxiety, C-reactive protein increased, Catheterisation cardiac normal, Chest discomfort
Clinical narrative: The patient had his 2nd Moderna vaccine on 4/21/21.  He had headache and malaise for 2 days that resolved. On 4/24, he developed chest pain radiating to his jaw and left upper arm.  He presented to the ED, he had an elevated troponin of 2.24 increased to 12.87. EKG showed ST elevation consistent with myocarditis.  He was transferred to RRH and underwent cardiac cath on 4/26 which showed no CAD. He was not febrile.  He was treated with metoprolol
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest pain, Hyperhidrosis, Limb discomfort, Myocarditis, Pain
Clinical narrative: The patient had his 2nd Moderna vaccine on 4/21/21.  He had headache and malaise for 2 days that resolved. On 4/24, he developed chest pain radiating to his jaw and left upper arm.  He presented to the ED, he had an elevated troponin of 2.24 increased to 12.87. EKG showed ST elevation consistent with myocarditis.  He was transferred to RRH and underwent cardiac cath on 4/26 which showed no CAD. He was not febrile.  He was treated with metoprolol
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pain in jaw, Troponin increased
Clinical narrative: The patient had his 2nd Moderna vaccine on 4/21/21.  He had headache and malaise for 2 days that resolved. On 4/24, he developed chest pain radiating to his jaw and left upper arm.  He presented to the ED, he had an elevated troponin of 2.24 increased to 12.87. EKG showed ST elevation consistent with myocarditis.  He was transferred to RRH and underwent cardiac cath on 4/26 which showed no CAD. He was not febrile.  He was treated with metoprolol
Age: 16.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Myocarditis
Clinical narrative: PFIZER-BIONTECH COVID-19 VACCINE EUA.  PATIENT'S MOM REPORTED THE FOLLOWING: HAD VOMITING ON 4/27 AT 9PM.  ON 4/28 EVENING HAD FEVER. CHEST PAINS ON 4/29 LATE EVENING. TIRED AND BODY ACHES THE WHOLE TIME.  FELT BETTER FRIDAY BUT CHEST PAINS OFF AND ON.  CONTACTED DOCTOR AND THEY DID BLOODWORK.  MD CALLED PEDIATRIC CARDIOLOGY AND ADMITTED TO  HOSPITAL WEEKEND OF MAY 1ST.  FOUND MYOCARDITIS AND  ALSO REPORTED TO VAERS.  HIS NUMBERS WERE IMPROVING WHILE AT HOSPITAL SO THAT IS WHAT THEY PUT ON DISCHARGE.   5/3- TROPONIN 0.68, CREATININE 4.8.
Age: 16.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood creatinine increased, Blood test, Chest pain, Fatigue, Myocarditis
Clinical narrative: PFIZER-BIONTECH COVID-19 VACCINE EUA.  PATIENT'S MOM REPORTED THE FOLLOWING: HAD VOMITING ON 4/27 AT 9PM.  ON 4/28 EVENING HAD FEVER. CHEST PAINS ON 4/29 LATE EVENING. TIRED AND BODY ACHES THE WHOLE TIME.  FELT BETTER FRIDAY BUT CHEST PAINS OFF AND ON.  CONTACTED DOCTOR AND THEY DID BLOODWORK.  MD CALLED PEDIATRIC CARDIOLOGY AND ADMITTED TO  HOSPITAL WEEKEND OF MAY 1ST.  FOUND MYOCARDITIS AND  ALSO REPORTED TO VAERS.  HIS NUMBERS WERE IMPROVING WHILE AT HOSPITAL SO THAT IS WHAT THEY PUT ON DISCHARGE.   5/3- TROPONIN 0.68, CREATININE 4.8.
Age: 16.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pain, Pyrexia, Troponin increased, Vomiting
Clinical narrative: PFIZER-BIONTECH COVID-19 VACCINE EUA.  PATIENT'S MOM REPORTED THE FOLLOWING: HAD VOMITING ON 4/27 AT 9PM.  ON 4/28 EVENING HAD FEVER. CHEST PAINS ON 4/29 LATE EVENING. TIRED AND BODY ACHES THE WHOLE TIME.  FELT BETTER FRIDAY BUT CHEST PAINS OFF AND ON.  CONTACTED DOCTOR AND THEY DID BLOODWORK.  MD CALLED PEDIATRIC CARDIOLOGY AND ADMITTED TO  HOSPITAL WEEKEND OF MAY 1ST.  FOUND MYOCARDITIS AND  ALSO REPORTED TO VAERS.  HIS NUMBERS WERE IMPROVING WHILE AT HOSPITAL SO THAT IS WHAT THEY PUT ON DISCHARGE.   5/3- TROPONIN 0.68, CREATININE 4.8.
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, COVID-19 pneumonia
Clinical narrative: Nurse Triage Open  4/25/2021 Call EMS 911 Now Disposition Extremity Weakness ? Fatigue Reason for call Conversation: Extremity Weakness (Oldest Message First) April 25, 2021   9:38 AM Emergency Contact contacted registered nurse   9:45 AM Note   Advised 911 now. Wife agreed.    Positive covid screen, cough Daughter in hospital with covid currently   Reason for Disposition ? Difficult to awaken or acting confused (e.g., disoriented, slurred speech)  Answer Assessment - Initial Assessment Questions 1. DESCRIPTION: "Describe how you are feeling."     Extreme Fatigue, difficult to awaken/keep awake 2. SEVERITY: "How bad is it?"  "Can you stand and walk?"   - MILD - Feels weak or tired, but does not interfere with work, school or normal activities   - MODERATE - Able to stand and walk; weakness interferes with work, school, or normal activities   - SEVERE - Unable to stand or walk     moderate 3. ONSET:  "When did the weakness begin?"     friday 4. CAUSE: "What do you think is causing the weakness?"     unsure 5. MEDICINES: "Have you recently started a new medicine or had a change in the amount of a medicine?"     denies 6. OTHER SYMPTOMS: "Do you have any other symptoms?" (e.g., chest pain, fever, cough, SOB, vomiting, diarrhea, bleeding, other areas of pain)     Cough  Had covid vaccine a week and half ago  Protocols used: WEAKNESS (GENERALIZED) AND FATIGUE    Hospital Course   81-year-old male admitted with COVID-19 infection.   COVID-19 infection: Reason for admission?patient completed course of remdesivir, plasma therapy. He was treated with IV dexamethasone?changed to oral medicine at the time of discharge.   Patient was requiring 2 to 3 L of oxygen via nasal cannula?we will continue and expect improvement down the road.   Hypertension: Controlled on metoprolol, amlodipine was added.   Deconditioning?seen by PT/OT?sending to rehab on 4/30.   Hard of hearing?advised to continue with hearing aid on discharge.   Discussed with patient's wife and updated about plan of care on day of discharge.   ED to Hosp-Admission Discharged  4/30/2021 - 5/6/2021 (6 days) Hospital MD Last attending ? Treatment team COVID-19 virus infection Principal problem Hospital Problem List   Chronic renal failure, stage 3 (moderate)  Essential hypertension  COVID-19 virus infection  Metabolic encephalopathy
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Adenovirus test, Alanine aminotransferase increased, Aspartate aminotransferase normal, Asthenia, Blood alkaline phosphatase normal
Clinical narrative: Nurse Triage Open  4/25/2021 Call EMS 911 Now Disposition Extremity Weakness ? Fatigue Reason for call Conversation: Extremity Weakness (Oldest Message First) April 25, 2021   9:38 AM Emergency Contact contacted registered nurse   9:45 AM Note   Advised 911 now. Wife agreed.    Positive covid screen, cough Daughter in hospital with covid currently   Reason for Disposition ? Difficult to awaken or acting confused (e.g., disoriented, slurred speech)  Answer Assessment - Initial Assessment Questions 1. DESCRIPTION: "Describe how you are feeling."     Extreme Fatigue, difficult to awaken/keep awake 2. SEVERITY: "How bad is it?"  "Can you stand and walk?"   - MILD - Feels weak or tired, but does not interfere with work, school or normal activities   - MODERATE - Able to stand and walk; weakness interferes with work, school, or normal activities   - SEVERE - Unable to stand or walk     moderate 3. ONSET:  "When did the weakness begin?"     friday 4. CAUSE: "What do you think is causing the weakness?"     unsure 5. MEDICINES: "Have you recently started a new medicine or had a change in the amount of a medicine?"     denies 6. OTHER SYMPTOMS: "Do you have any other symptoms?" (e.g., chest pain, fever, cough, SOB, vomiting, diarrhea, bleeding, other areas of pain)     Cough  Had covid vaccine a week and half ago  Protocols used: WEAKNESS (GENERALIZED) AND FATIGUE    Hospital Course   81-year-old male admitted with COVID-19 infection.   COVID-19 infection: Reason for admission?patient completed course of remdesivir, plasma therapy. He was treated with IV dexamethasone?changed to oral medicine at the time of discharge.   Patient was requiring 2 to 3 L of oxygen via nasal cannula?we will continue and expect improvement down the road.   Hypertension: Controlled on metoprolol, amlodipine was added.   Deconditioning?seen by PT/OT?sending to rehab on 4/30.   Hard of hearing?advised to continue with hearing aid on discharge.   Discussed with patient's wife and updated about plan of care on day of discharge.   ED to Hosp-Admission Discharged  4/30/2021 - 5/6/2021 (6 days) Hospital MD Last attending ? Treatment team COVID-19 virus infection Principal problem Hospital Problem List   Chronic renal failure, stage 3 (moderate)  Essential hypertension  COVID-19 virus infection  Metabolic encephalopathy
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood bilirubin normal, Blood calcium normal, Blood chloride normal, Blood creatinine increased, Blood magnesium normal
Clinical narrative: Nurse Triage Open  4/25/2021 Call EMS 911 Now Disposition Extremity Weakness ? Fatigue Reason for call Conversation: Extremity Weakness (Oldest Message First) April 25, 2021   9:38 AM Emergency Contact contacted registered nurse   9:45 AM Note   Advised 911 now. Wife agreed.    Positive covid screen, cough Daughter in hospital with covid currently   Reason for Disposition ? Difficult to awaken or acting confused (e.g., disoriented, slurred speech)  Answer Assessment - Initial Assessment Questions 1. DESCRIPTION: "Describe how you are feeling."     Extreme Fatigue, difficult to awaken/keep awake 2. SEVERITY: "How bad is it?"  "Can you stand and walk?"   - MILD - Feels weak or tired, but does not interfere with work, school or normal activities   - MODERATE - Able to stand and walk; weakness interferes with work, school, or normal activities   - SEVERE - Unable to stand or walk     moderate 3. ONSET:  "When did the weakness begin?"     friday 4. CAUSE: "What do you think is causing the weakness?"     unsure 5. MEDICINES: "Have you recently started a new medicine or had a change in the amount of a medicine?"     denies 6. OTHER SYMPTOMS: "Do you have any other symptoms?" (e.g., chest pain, fever, cough, SOB, vomiting, diarrhea, bleeding, other areas of pain)     Cough  Had covid vaccine a week and half ago  Protocols used: WEAKNESS (GENERALIZED) AND FATIGUE    Hospital Course   81-year-old male admitted with COVID-19 infection.   COVID-19 infection: Reason for admission?patient completed course of remdesivir, plasma therapy. He was treated with IV dexamethasone?changed to oral medicine at the time of discharge.   Patient was requiring 2 to 3 L of oxygen via nasal cannula?we will continue and expect improvement down the road.   Hypertension: Controlled on metoprolol, amlodipine was added.   Deconditioning?seen by PT/OT?sending to rehab on 4/30.   Hard of hearing?advised to continue with hearing aid on discharge.   Discussed with patient's wife and updated about plan of care on day of discharge.   ED to Hosp-Admission Discharged  4/30/2021 - 5/6/2021 (6 days) Hospital MD Last attending ? Treatment team COVID-19 virus infection Principal problem Hospital Problem List   Chronic renal failure, stage 3 (moderate)  Essential hypertension  COVID-19 virus infection  Metabolic encephalopathy
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood potassium normal, Blood sodium normal, Blood urea increased, Bordetella test negative, COVID-19
Clinical narrative: Nurse Triage Open  4/25/2021 Call EMS 911 Now Disposition Extremity Weakness ? Fatigue Reason for call Conversation: Extremity Weakness (Oldest Message First) April 25, 2021   9:38 AM Emergency Contact contacted registered nurse   9:45 AM Note   Advised 911 now. Wife agreed.    Positive covid screen, cough Daughter in hospital with covid currently   Reason for Disposition ? Difficult to awaken or acting confused (e.g., disoriented, slurred speech)  Answer Assessment - Initial Assessment Questions 1. DESCRIPTION: "Describe how you are feeling."     Extreme Fatigue, difficult to awaken/keep awake 2. SEVERITY: "How bad is it?"  "Can you stand and walk?"   - MILD - Feels weak or tired, but does not interfere with work, school or normal activities   - MODERATE - Able to stand and walk; weakness interferes with work, school, or normal activities   - SEVERE - Unable to stand or walk     moderate 3. ONSET:  "When did the weakness begin?"     friday 4. CAUSE: "What do you think is causing the weakness?"     unsure 5. MEDICINES: "Have you recently started a new medicine or had a change in the amount of a medicine?"     denies 6. OTHER SYMPTOMS: "Do you have any other symptoms?" (e.g., chest pain, fever, cough, SOB, vomiting, diarrhea, bleeding, other areas of pain)     Cough  Had covid vaccine a week and half ago  Protocols used: WEAKNESS (GENERALIZED) AND FATIGUE    Hospital Course   81-year-old male admitted with COVID-19 infection.   COVID-19 infection: Reason for admission?patient completed course of remdesivir, plasma therapy. He was treated with IV dexamethasone?changed to oral medicine at the time of discharge.   Patient was requiring 2 to 3 L of oxygen via nasal cannula?we will continue and expect improvement down the road.   Hypertension: Controlled on metoprolol, amlodipine was added.   Deconditioning?seen by PT/OT?sending to rehab on 4/30.   Hard of hearing?advised to continue with hearing aid on discharge.   Discussed with patient's wife and updated about plan of care on day of discharge.   ED to Hosp-Admission Discharged  4/30/2021 - 5/6/2021 (6 days) Hospital MD Last attending ? Treatment team COVID-19 virus infection Principal problem Hospital Problem List   Chronic renal failure, stage 3 (moderate)  Essential hypertension  COVID-19 virus infection  Metabolic encephalopathy
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Carbon dioxide normal, Chest X-ray abnormal, Chlamydia test negative, Computerised tomogram head abnormal, Confusional state
Clinical narrative: Nurse Triage Open  4/25/2021 Call EMS 911 Now Disposition Extremity Weakness ? Fatigue Reason for call Conversation: Extremity Weakness (Oldest Message First) April 25, 2021   9:38 AM Emergency Contact contacted registered nurse   9:45 AM Note   Advised 911 now. Wife agreed.    Positive covid screen, cough Daughter in hospital with covid currently   Reason for Disposition ? Difficult to awaken or acting confused (e.g., disoriented, slurred speech)  Answer Assessment - Initial Assessment Questions 1. DESCRIPTION: "Describe how you are feeling."     Extreme Fatigue, difficult to awaken/keep awake 2. SEVERITY: "How bad is it?"  "Can you stand and walk?"   - MILD - Feels weak or tired, but does not interfere with work, school or normal activities   - MODERATE - Able to stand and walk; weakness interferes with work, school, or normal activities   - SEVERE - Unable to stand or walk     moderate 3. ONSET:  "When did the weakness begin?"     friday 4. CAUSE: "What do you think is causing the weakness?"     unsure 5. MEDICINES: "Have you recently started a new medicine or had a change in the amount of a medicine?"     denies 6. OTHER SYMPTOMS: "Do you have any other symptoms?" (e.g., chest pain, fever, cough, SOB, vomiting, diarrhea, bleeding, other areas of pain)     Cough  Had covid vaccine a week and half ago  Protocols used: WEAKNESS (GENERALIZED) AND FATIGUE    Hospital Course   81-year-old male admitted with COVID-19 infection.   COVID-19 infection: Reason for admission?patient completed course of remdesivir, plasma therapy. He was treated with IV dexamethasone?changed to oral medicine at the time of discharge.   Patient was requiring 2 to 3 L of oxygen via nasal cannula?we will continue and expect improvement down the road.   Hypertension: Controlled on metoprolol, amlodipine was added.   Deconditioning?seen by PT/OT?sending to rehab on 4/30.   Hard of hearing?advised to continue with hearing aid on discharge.   Discussed with patient's wife and updated about plan of care on day of discharge.   ED to Hosp-Admission Discharged  4/30/2021 - 5/6/2021 (6 days) Hospital MD Last attending ? Treatment team COVID-19 virus infection Principal problem Hospital Problem List   Chronic renal failure, stage 3 (moderate)  Essential hypertension  COVID-19 virus infection  Metabolic encephalopathy